- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01326975
Effect of Continuous Positive Airway Pressure Delivered by Two Different Modalities on Breathing Pattern in Preterm Infants
Effects of Continuous Positive Airway Pressure (CPAP) Delivered by High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure on the Diaphragm Electrical Activity in Very Low Birth Weight Preterm Infants
Study Overview
Status
Conditions
Detailed Description
Many preterm very low birth weight infants require continuous positive airway pressure(CPAP) for breathing support because of lung immaturity. CPAP can be delivered by the infant flow(TM) device which is well studied. Prolonged use of nasal prongs CPAP has been shown to cause discomfort and, rarely, nasal injury leading to long term disfigurement. On the other hand, High flow nasal cannula (HFNC) ,which is another modality of delivering CPAP, creates less pressure on the nose and less disfiguring effect but previous research showed that the use of HFNC may be less effective than IF-CPAP in providing breathing support in these infants.
We plan to study 10 stable preterm infants born less than 32 weeks' gestation and 1.5 kilograms at birth after being stable for at least 48hours on IF-CPAP. babies will be randomized to start on IF-CPAP or HFNC for 30 minutes. After 45 minutes of adaptation, baby will be switched to the other modality for another 30 minutes. By inserting a specialized feeding tube with sensors into the stomach, we can measure the electrical activity of the diaphragm (EAdi). By analysing EAdi with each modality of delivering CPAP, we want to directly assess how HFNC affects breathing compared to IF-CPAP.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Birth weights ≤ 1500g
- Gestational age less than 32 week
- Stable on nasal continuous positive airway pressure (CPAP) of 5-6cmH20 support for at least 48 hours
- Treated with methylxanthines for apnea of prematurity
- In less than 35% oxygen
Exclusion Criteria:
- Congenital and acquired problem of the gastrointestinal tract
- Phrenic nerve injury and/or diaphragm paralysis
- Esophageal perforation/tracheoesophageal fistula
- Congenital/acquired neurological deficit and/or seizures
- Hemodynamic instability
- Congenital heart disease (including symptomatic patent ductus arteriosus)
- Undergoing treatment for sepsis or pneumonia
- Use of muscle relaxants, narcotic analgesics, or gastric motility agents
- Congenital anomalies of respiratory tract (e.g. CCAM)
- Infants requiring more than 35% oxygen
- Infants with facial anomalies
- Infants with pneumothorax and/or pneumomediatinum
- Infants in the immediate postoperative period
- Infants with significant gastric residues and vomiting
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
EAdi 1
babies in this group will first receive CPAP through IF-CPAP for 30 minutes.
After another 45 minutes, they will be switched to HFNC for 30 minutes.
EAdi will be recorded for the last 15 minutes of each 30 minutes period.
|
|
EAdi 2
babies in this group will first receive CPAP through HFNC for 30 minutes.
After another 45 minutes, they will be switched to IF-CPAP for 30 minutes.
EAdi will be recorded for the last 15 minutes of each 30 minutes period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference in the tonic EAdi between IF-CPAP and HFNC .
Time Frame: During the 4-hour study period.
|
Patients will be randomized in two groups, one group will start on IF-CPAP for 30 minutes.
After another 45 minutes, this group will be switched to HFNC for another 30 minutes.
The other group will start on HFNC and then switched to IF-CPAP.
EAdi will be analyzed in the last 15 minutes of each 30 minutes period.
|
During the 4-hour study period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in the number of apnea episodes (breathing pauses) on EAdi recorded with each modality.
Time Frame: During the 4-hour study period.
|
During the 4-hour study period.
|
|
|
Difference in episodes of clinically significant apnea with HFNC and IF-CPAP.
Time Frame: During the 4-hour study period.
|
During the 4-hour study period.
|
|
|
Indices of respiratory muscle effort (inspiratory and expiratory) will be calculated from Edi waveform.
Time Frame: During the 4-hour study period.
|
These indices include the phasic Edi to the peak, mean inspiratory Edi, Edi-time product, post inspiratory activity and all neural timings.
|
During the 4-hour study period.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Michael Dunn, MD, Sunnybrook Health Sciences Centre
- Principal Investigator: Nehad Nasef, M.B.B.Ch, Sunnybrook Health Sciences Centre
- Principal Investigator: Maureen Reilly, RRT, Sunnybrook Health Sciences Centre
- Principal Investigator: Patti Schurr, RN(EC), Sunnybrook Health Sciences Centre
- Principal Investigator: Jennifer Beck, Ph.D., Unity Health Toronto
- Study Director: Eugene Ng, MD, Sunnybrook Health Sciences Centre
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 254-2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Continuous Positive Airway Pressure
-
Sohag UniversityNot yet recruiting
-
Universidade Federal do Rio Grande do NorteUniversidade Estadual da ParaibaRecruitingContinuous Positive Airway Pressure | Cardiac Surgical Procedures | BIPAP Biphasic Intermittent Positive Airway PressureBrazil
-
University Hospital, MontpellierAssociation pour l'Assistance et la Réhabilitation à Domicile (APARD)CompletedNoninvasive Ventilation | Continuous Positive Airway PressureFrance
-
Medical University InnsbruckCompletedContinuous Positive Airway Pressure | CPAP VentilationAustria
-
Umeå UniversityNot yet recruitingAbdominal Surgery | Continuous Positive Airway Pressure | Lung FunctionSweden
-
Rambam Health Care CampusCompletedOne Lung Ventilation | Continuous Positive Airway Pressure | Differential Lung VentilationIsrael
-
Ataturk UniversityCompleted
-
Nguyen Dang ThuCompletedOlder People | Pulmonary Function | Continuous Positive Airway PressureVietnam
-
Universitätsklinikum Hamburg-EppendorfCompletedObesity | Endoscopy | Continuous Positive Airway Pressure | OxygenationGermany
-
Instituto Materno Infantil Prof. Fernando FigueiraCompletedHypoxia | General Anesthesia | Continuous Positive Airway PressureBrazil